Time interval between hCG administration and oocyte pick up: analysis of oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome

Objective: To investigate associations of the time interval between hCG administration and oocyte pick up with oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome, in different age groups. Design: A retrospective cohort study. Setting: An academic medical center. Patients: Women...

Full description

Saved in:
Bibliographic Details
Main Authors: Sivan Skvirsky, Idit Blais, Shirly Lahav-Baratz, Mara Koifman, Zofnat Wiener-Megnazi, Martha Dirnfeld
Format: Article
Language:English
Published: IMR Press 2021-04-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/48/2/10.31083/j.ceog.2021.02.2284
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To investigate associations of the time interval between hCG administration and oocyte pick up with oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome, in different age groups. Design: A retrospective cohort study. Setting: An academic medical center. Patients: Women who underwent IVF and ICSI cycles in which all oocytes were incubated in a time lapse microscopy system (EmbryoScope). Cycles were stratified by age and time from hCG exposure. Interventions: None. Main Outcome Measures: Of 2185 IVF/ICSI OPU cycles, 820 cycles were included in the analysis. Final analysis was made on 796 cycles (4930 oocytes). Oocyte number and their maturity, fertilization rates, and embryo quality defined by morphology and morphokinetics, clinical pregnancy, and live birth rates. Results: The median hCG-oocyte pick up (OPU) interval was 34.45 hours. Among women over age 36 years, longer intervals were associated with both a higher fraction of mature oocytes (P < 0.008) and better morphology grading of embryos (P < 0.01). At all ages and all intervals, those with cleavage time, t2 ≤ 27 hours achieved a statistically significant higher clinical pregnancy rate. No differences were found in morphokinetics (t2) between different hCG-OPU intervals for any of the age groups. Conclusions: Extending hCG to OPU interval may be beneficial for patients aged > 36 years, as more mature eggs and better embryo morphology were achieved. In older women with fewer oocytes retrieved, even a small extra number of mature oocytes may prove crucial for treatment outcome and improve success rates. A prospective, randomized study is warranted to determine whether optimal hGC-retrieval time interval merits revision/adjustment for older women.
ISSN:0390-6663